EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2

Van Laere K., Varrone A., Booij J., Borght T. V., Nobili F., Kapucu O. L., ...Daha Fazla

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, cilt.37, sa.2, ss.434-442, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 37 Sayı: 2
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1007/s00259-009-1265-z
  • Dergi Adı: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.434-442
  • Anahtar Kelimeler: Brain, Dopamine, D2 receptor, SPECT, PET, Parkinsonism, MULTIPLE SYSTEM ATROPHY, POSITRON-EMISSION-TOMOGRAPHY, PARKINSONS-DISEASE, DIFFERENTIAL-DIAGNOSIS, HUNTINGTONS-DISEASE, AUTOMATED QUANTIFICATION, COMPUTED-TOMOGRAPHY, I-123 IODOBENZAMIDE, PET, NEUROLEPTICS
  • Gazi Üniversitesi Adresli: Evet

Özet

The guidelines summarize the current views of the European Association of Nuclear Medicine Neuroimaging Committee (ENC). The aims of the guidelines are to assist nuclear medicine practitioners in making recommendations, performing, interpreting and reporting the results of clinical dopamine D2 receptor SPECT or PET studies, and to achieve a high quality standard of dopamine D2 receptor imaging, which will increase the impact of this technique in neurological practice.